England Health Agency Bars Puberty Blockers For Children

England recently pushed away from harmful left-wing “transgender” ideology by announcing that children in the country will no longer receive puberty blocker prescriptions after experts reported serious safety concerns.

England’s National Health Service (NHS) made its decision after commissioning the National Institute for Health and Care Excellence (NICE) to review published evidence on Gonadotrophin Releasing Hormone Analogues (GnRHa), known as puberty blockers, which bar the body from producing gender hormones needed for an individual to grow into an adult.

“NHS England has carefully considered the evidence review conducted by NICE (2020) and has identified and reviewed any further published evidence available to date,” a policy document from NHS England read. “We have concluded that there is not enough evidence to support the safety or clinical effectiveness of PSH to make the treatment routinely available at this time.”

The Daily Wire reported that the NHS’ investigation came after an increase in children being referred to a national health clinic in the U.K. called the “Gender Identity Development Service.” In 2022, 250 children were sent to the clinic. Such a figure rose to over 5,000 in 2022 as the “transgender” movement gained prominence worldwide.

Less than 100 children in the U.K. are currently on puberty blockers and are being monitored by endocrinologists at Leeds and University College London Hospital. Such individuals will be allowed to continue accessing the harmful drugs through the NHS, but they will no longer receive prescriptions from the organization.

In June 2023, the Washington Examiner reported that NHS was considering prohibiting minors from receiving puberty blockers because there was a link between gender dysphoria and other developmental issues.

“A significant proportion of children and young people who are concerned about, or distressed by, issues of gender incongruence experience coexisting mental health, neuro-developmental and/or personal, family or social complexities in their lives,” a 25-page report stated at the time.

“The relationship between these presentations and gender incongruence may not be really apparent and will often require careful exploration,” the report continued.

Republicans in the U.S. have opposed providing minors with so-called “gender-affirming care,” which includes puberty blockers. In Missouri, Florida and Louisiana, elected officials have taken steps to ban children from receiving such treatment.